Healthcare
Rennova Health, Inc.(RNVA)
Live Price
Offline$0.0001
+0.00% today
1Y Change
+0.00%
Window
Jun 20, 2025 โ Jun 17, 2026
- Market Cap
- โ
- Revenue Growth
- +43.3%
- EPS Growth
- +99.4%
- Dividend Yield
- 0.0%
Coverage: 249 bars ยท Jun 20, 2025 โ Jun 17, 2026
Research Briefing
A compact read on the setup, peer context, quarterly changes, and recent earnings reaction.
Research Snapshot
Rennova Health, Inc. (RNVA) is a Healthcare stock with listed on OTC. The stock last traded around $0.00 and up 0.0% across the available one-year price window (Jun 20, 2025 โ Jun 17, 2026). Baseline metrics include revenue growth of +43.3%, EPS growth of +99.4%, a dividend yield of 0.0%. What stands out right now is revenue +43.3%, EPS +99.4%, free cash flow +1297.6% with operating margin 7.3% and ROIC -7.2%. Valuation is more restrained than many high-expectation growth names at price/sales 0.2. Overall, the current profile looks closer to a higher-growth but lower-margin setup than a generic broad-market placeholder. Stock Foundry combines RNVA price history, valuation, growth, dividend context, earnings, analyst forecasts, news, related Healthcare peers on this page.
Sector Context
How this name stacks up against nearby peers on first-pass metrics.
Revenue Growth
Above sector median
+43.3% vs +7.6% peer median
Operating Margin
Below sector median
+7.3% vs +19.4% peer median
What Changed This Quarter
Latest report context and the signals most likely to have changed the story.
Latest report is on the board
2023 was reported on Nov 14, 2023, but the surprise data is still limited.
The operating story is still moving forward
Revenue is running at +43.3% and EPS at +99.4%, with operating margin around 7.3%.
Earnings Reaction Memory
How the stock has tended to move after recent reports.
Across the last 3 reported quarters, the stock averaged 0.0% over the next 5 trading days and finished higher after 0 of those reports.
View quarter-by-quarter reaction table
| Quarter | EPS ฮ | 1D | 5D | 20D |
|---|---|---|---|---|
2023 Nov 14, 2023 | โ | +0.0% | +0.0% | +0.0% |
2023 Aug 15, 2023 | โ | +0.0% | +0.0% | +0.0% |
2023 May 15, 2023 | โ | +0.0% | +0.0% | +0.0% |
Benchmark Comparison
Normalized Performance vs SPY
Compare this ticker against a broad index, growth benchmark, or sector ETF using a shared 1Y normalization window.
RNVA
โ
Normalized return
SPY
โ
S&P 500
Excess Return
โ
Relative to SPY
RNVA Max Drawdown
0.00%
Trailing 1Y
SPY Max Drawdown
โ
Trailing 1Y
Calendar-Year Returns
Uses the longest available daily history for RNVA and SPY.
Company Overview
Rennova Health, Inc.
Other OTC
Rennova Health, Inc., together with its subsidiaries, provides health care services in the United States. As of December 31, 2021, it owns one operating hospital in Oneida, Tennessee; an acute care hospital and a physician's practice in Jamestown, Tennessee; and a rural clinic in Williamsburg, Kentucky. The company was founded in 2005 and is based in West Palm Beach, Florida.
- Leadership
- Seamus Lagan
- IPO Date
- Oct 19, 1995
- Employees
- 96
- Street Address
- 400 South Australian Avenue
- Mailing
- West Palm Beach, FL, 33401
- Region
- West Palm Beach, FL, US
- Reporting Currency
- USD
- Investor Line
- 561 855 1626
- Last Updated
- May 4, 2026
Key Fundamentals
Valuation, growth, profitability, and balance sheet signals.
Valuation
- P/E
- โ
- EV/EBITDA
- 11.1
- Price/Sales
- 0.2
- Price/Book
- โ
Growth
- Revenue
- +43.3%
- EPS
- +99.4%
- Free Cash Flow
- +1297.6%
Profitability
- Gross Margin
- 59.5%
- Operating Margin
- 7.3%
- Net Margin
- -41.4%
- ROE
- 23.5%
- ROIC
- -7.2%
Balance Sheet
- Debt/Equity
- โ
- Current Ratio
- 0.16
Earnings Reports
Latest News
Official Releases
Company announcements and filings-style updates.
Next Step
Keep the research moving
After the overview, the strongest next step is usually chart context or a tighter compare set.